article thumbnail

Claims that AI will “revolutionise pharma R&D” are (almost entirely) hype

DrugBaron

Intelligence (artificial or organic) makes the best use of the available information to guide future decisions. But that presumes that the necessary information to make a better decision exists and is available. Only if the necessary information to select valid targets already exists in the totality of the data available.